GERALD MARSHBANKS: Open Payments
NPI 1225129646 · BRADENTON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 32 payments from 13 companies in 2025. Trend: 2023 $615 · 2024 $1,003 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 5 | $115 |
| Exact Sciences Corporation | 4 | $86 |
| Indivior Inc. | 3 | $67 |
| PFIZER INC. | 3 | $62 |
| ABBVIE INC. | 3 | $51 |
| CSL Behring | 1 | $25 |
| STRATA Skin Sciences, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
Products named: REXULTI, SUBLOCADE, Cologuard Collection Kit, VRAYLAR, PREVNAR 20, Wegovy, Ozempic, Hizentra.
Industry payments across FL — which companies pay providers there.
